As the year draws to an end the Medical Device Network looks back at some of the biggest events of 2023 in the medical device industry.
According to GlobalData, the global cell and gene therapy market is expected to reach $80bn by 2029.
The collaboration between Sanofi and Aqemia is not just a financial transaction; it signifies a broader shift in the industry towards embracing AI.
Stryker is the market leader in this segment as many of its robotic surgery suites require these features to function.
The device, which is already CE marked, could join a US vascular stent market expected to reach $2bn by 2033.
Individuals aged 22 years or older who do not respond to traditional dilation are eligible to participate in the study.
The less invasive device obtains blood samples through a simple fingerstick.